Orwin John A
Insider CIK 1477384 · SGEN Director · ARRY Director · AFFY CEO, Director · ANAB Director · NGSX Director · RLYP President & CEO, Director · RTRX Director · BCEL President & CEO, Director · CRGX Director · TRAX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TRAX First Tracks Biotherapeuti | M Exercise deriv | 2026-09-15 | 2026-09-17 | 1,300 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise deriv | 2026-09-15 | 2026-09-17 | 1,300 | — | $0 | 0 | SEC↗ |
| TRAX First Tracks Biotherapeuti | M Exercise | 2026-09-15 | 2026-09-17 | 1,300 | — | $0 | 17,995 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise | 2026-09-15 | 2026-09-17 | 1,300 | — | $0 | 17,995 | SEC↗ |
| TRAX First Tracks Biotherapeuti | M Exercise deriv | 2026-09-15 | 2026-09-17 | 1,300 | — | $0 | 0 | SEC↗ |
| TRAX First Tracks Biotherapeuti | M Exercise | 2026-09-15 | 2026-09-17 | 1,300 | — | $0 | 17,995 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise deriv | 2026-09-15 | 2026-09-17 | 1,300 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise | 2026-09-15 | 2026-09-17 | 1,300 | — | $0 | 17,995 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise deriv | 2026-06-15 | 2026-06-17 | 6,030 | — | $0 | 0 | SEC↗ |
| TRAX First Tracks Biotherapeuti | M Exercise deriv | 2026-06-15 | 2026-06-17 | 6,030 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise | 2026-06-15 | 2026-06-17 | 6,030 | — | $0 | 16,695 | SEC↗ |
| TRAX First Tracks Biotherapeuti | M Exercise | 2026-06-15 | 2026-06-17 | 6,030 | — | $0 | 16,695 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2026-05-19 | 2026-05-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2026-05-19 | 2026-05-21 | 4,000 | — | $0 | 39,375 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-05-12 | 2026-05-14 | 42,000 | — | $0 | 42,000 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-05-12 | 2026-05-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-05-12 | 2026-06-12 | 7,000 | — | $0 | 7,000 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-05-12 | 2026-06-12 | 2,500 | — | $0 | 2,500 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-04-20 | 2026-04-22 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-04-20 | 2026-04-22 | 3,311 | — | $0 | 3,311 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-04-20 | 2026-04-22 | 10,600 | — | $0 | 10,600 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-04-20 | 2026-04-22 | 16,510 | — | $0 | 16,510 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-04-20 | 2026-04-22 | 16,510 | — | $0 | 16,510 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-04-20 | 2026-04-22 | 8,250 | — | $0 | 8,250 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-04-20 | 2026-04-22 | 1,300 | — | $0 | 1,300 | SEC↗ |
| TRAX First Tracks Biotherapeuti | A Award deriv | 2026-04-20 | 2026-04-22 | 6,030 | — | $0 | 6,030 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-04-20 | 2026-04-22 | 8,250 | — | $0 | 8,250 | SEC↗ |
| ANAB ANAPTYSBIO, INC | D To issuer deriv | 2026-04-20 | 2026-04-22 | 16,510 | — | $0 | 16,510 | SEC↗ |
| ANAB ANAPTYSBIO, INC | D To issuer deriv | 2026-04-20 | 2026-04-22 | 3,311 | — | $0 | 3,311 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-04-20 | 2026-04-22 | 3,311 | — | $0 | 3,311 | SEC↗ |
| ANAB ANAPTYSBIO, INC | D To issuer deriv | 2026-04-20 | 2026-04-22 | 10,600 | — | $0 | 10,600 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-04-20 | 2026-04-22 | 10,600 | — | $0 | 10,600 | SEC↗ |
| ANAB ANAPTYSBIO, INC | D To issuer deriv | 2026-04-20 | 2026-04-22 | 8,250 | — | $0 | 8,250 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-04-20 | 2026-04-22 | 16,510 | — | $0 | 16,510 | SEC↗ |
| ANAB ANAPTYSBIO, INC | D To issuer deriv | 2026-04-20 | 2026-04-22 | 16,510 | — | $0 | 16,510 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-04-20 | 2026-04-22 | 16,510 | — | $0 | 16,510 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-01-06 | 2026-01-08 | 8,250 | — | $0 | 8,250 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-01-06 | 2026-01-08 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise deriv | 2025-09-15 | 2025-09-17 | 1,300 | — | $0 | 1,300 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise | 2025-09-15 | 2025-09-17 | 1,300 | — | $0 | 10,665 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | D To issuer deriv | 2025-08-19 | 2025-08-19 | 15,865 | — | $0 | 0 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | D To issuer deriv | 2025-08-19 | 2025-08-19 | 25,000 | — | $0 | 0 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise deriv | 2025-06-15 | 2025-06-17 | 6,030 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise | 2025-06-15 | 2025-06-17 | 6,030 | — | $0 | 9,365 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2025-05-15 | 2025-05-16 | 19,500 | — | $0 | 19,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2025-05-15 | 2025-05-16 | 6,500 | — | $0 | 35,375 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2025-01-07 | 2025-01-07 | 6,030 | — | $0 | 6,030 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2025-01-07 | 2025-01-07 | 16,510 | — | $0 | 16,510 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise deriv | 2024-09-15 | 2024-09-17 | 1,300 | — | $0 | 2,600 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise | 2024-09-15 | 2024-09-17 | 1,300 | — | $0 | 3,335 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise deriv | 2024-06-15 | 2024-06-18 | 2,035 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise | 2024-06-15 | 2024-06-18 | 2,035 | — | $0 | 2,035 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | A Award deriv | 2024-06-04 | 2024-06-06 | 23,742 | — | $0 | 23,742 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2024-05-08 | 2024-05-10 | 19,500 | — | $0 | 19,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2024-05-08 | 2024-05-10 | 6,500 | — | $0 | 28,875 | SEC↗ |
| BCEL Atreca, Inc. | P Buy | 2024-04-11 | 2024-04-17 | 1 | $0.01 | $0 | 1 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2024-01-03 | 2024-01-05 | 16,510 | — | $0 | 16,510 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2024-01-03 | 2024-01-05 | 6,030 | — | $0 | 6,030 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 7,038 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 2,044 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 3,676 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 12,500 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 9,260 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 9,260 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 9,260 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 9,260 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 3,171 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 3,462 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer | 2023-12-14 | 2023-12-15 | 29,003 | $229.00 | $6.64M | 0 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | A Award deriv | 2023-11-09 | 2023-11-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2023-09-15 | 2023-09-18 | 3,900 | — | $0 | 3,900 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2023-09-15 | 2023-09-18 | 2,035 | — | $0 | 2,035 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2023-09-15 | 2023-09-18 | 3,311 | — | $0 | 3,311 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2023-09-15 | 2023-09-18 | 10,600 | — | $0 | 10,600 | SEC↗ |
| BCEL Atreca, Inc. | S Sale | 2023-09-01 | 2024-04-03 | 22,951 | $0.37 | $8.5K | 77,541 | SEC↗ |
| SGEN Seagen Inc. | A Award | 2023-05-31 | 2023-06-02 | 2,044 | — | $0 | 31,047 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2023-05-17 | 2023-05-19 | 13,500 | — | $0 | 13,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2023-05-17 | 2023-05-19 | 4,500 | — | $0 | 22,375 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2023-02-09 | 2023-02-13 | 435,000 | — | $0 | 435,000 | SEC↗ |
| BCEL Atreca, Inc. | S Sale | 2022-09-02 | 2022-09-20 | 20,908 | $1.78 | $37.2K | 100,492 | SEC↗ |
| BCEL Atreca, Inc. | D To issuer deriv | 2022-06-13 | 2022-06-15 | 260,000 | — | $0 | 0 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2022-06-13 | 2022-06-15 | 241,000 | — | $0 | 241,000 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2022-06-13 | 2022-06-15 | 260,000 | — | $0 | 260,000 | SEC↗ |
| BCEL Atreca, Inc. | D To issuer deriv | 2022-06-13 | 2022-06-15 | 241,000 | — | $0 | 0 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2022-06-13 | 2022-06-15 | 148,754 | — | $0 | 148,754 | SEC↗ |
| BCEL Atreca, Inc. | D To issuer deriv | 2022-06-13 | 2022-06-15 | 148,754 | — | $0 | 0 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2022-06-13 | 2022-06-15 | 58,995 | — | $0 | 58,995 | SEC↗ |
| BCEL Atreca, Inc. | D To issuer deriv | 2022-06-13 | 2022-06-15 | 58,995 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | A Award deriv | 2022-05-13 | 2022-05-17 | 3,676 | — | $0 | 3,676 | SEC↗ |
| SGEN Seagen Inc. | A Award | 2022-05-13 | 2022-05-17 | 1,503 | — | $0 | 29,003 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-05-11 | 2022-05-12 | 9,000 | — | $0 | 9,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2022-05-11 | 2022-05-12 | 3,000 | — | $0 | 17,875 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2021-12-23 | 2021-12-28 | 260,000 | — | $0 | 260,000 | SEC↗ |
| BCEL Atreca, Inc. | A Award | 2021-09-09 | 2021-09-13 | 115,400 | — | $0 | 121,400 | SEC↗ |
| SGEN Seagen Inc. | A Award deriv | 2021-05-14 | 2021-05-18 | 3,462 | — | $0 | 3,462 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2021-05-14 | 2021-05-18 | 9,000 | — | $0 | 9,000 | SEC↗ |
| SGEN Seagen Inc. | A Award | 2021-05-14 | 2021-05-18 | 1,402 | — | $0 | 27,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-05-14 | 2021-05-18 | 3,000 | — | $0 | 14,875 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2021-01-27 | 2021-01-29 | 260,000 | — | $0 | 260,000 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2020-05-15 | 2020-05-19 | 3,171 | — | $0 | 3,171 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-05-15 | 2020-05-19 | 9,000 | — | $0 | 9,000 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2020-05-15 | 2020-05-19 | 1,335 | — | $0 | 26,098 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-05-15 | 2020-05-19 | 3,000 | — | $0 | 11,875 | SEC↗ |
| BCEL Atreca, Inc. | P Buy | 2020-03-17 | 2020-03-19 | 6,000 | $12.79 | $76.7K | 6,000 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2020-02-26 | 2020-02-28 | 241,000 | — | $0 | 241,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 20,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 25,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 25,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 25,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 25,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 25,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 25,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer | 2019-07-30 | 2019-07-30 | 5,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer | 2019-07-30 | 2019-07-30 | 15,000 | $48.00 | $720.0K | 5,000 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2019-05-20 | 2019-05-22 | 7,038 | — | $0 | 7,038 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2019-05-20 | 2019-05-22 | 2,963 | — | $0 | 24,763 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2019-05-08 | 2019-05-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2019-05-08 | 2019-05-10 | 2,000 | — | $0 | 8,875 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-10-26 | 2018-10-29 | 5,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-10-26 | 2018-10-29 | 5,000 | — | $0 | 15,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2018-10-25 | 2018-10-29 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2018-10-25 | 2018-10-29 | 5,000 | — | $0 | 5,000 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2018-05-18 | 2018-05-22 | 9,260 | — | $0 | 9,260 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2018-05-18 | 2018-05-22 | 3,700 | — | $0 | 21,800 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2018-05-09 | 2018-05-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-05-09 | 2018-05-11 | 2,500 | — | $0 | 6,875 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-10-27 | 2017-10-27 | 5,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-10-27 | 2017-10-27 | 5,000 | $10.47 | $52.4K | 10,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2017-10-26 | 2017-10-27 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2017-10-26 | 2017-10-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2017-05-19 | 2017-05-23 | 9,260 | — | $0 | 9,260 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2017-05-19 | 2017-05-23 | 3,700 | — | $0 | 18,100 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2017-03-23 | 2017-03-27 | 17,500 | — | $0 | 17,500 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2017-03-23 | 2017-03-27 | 4,375 | — | $0 | 4,375 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2016-10-29 | 2016-10-31 | 5,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2016-10-29 | 2016-10-31 | 5,000 | $5.83 | $29.1K | 5,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-10-27 | 2016-10-31 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-10-27 | 2016-10-31 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 727,877 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 94,500 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 105,000 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 67,500 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2016-09-01 | 2016-09-02 | 45,000 | — | $0 | 67,500 | SEC↗ |
| RLYP Relypsa Inc | U Tender | 2016-09-01 | 2016-09-02 | 10,142 | $32.00 | $324.5K | 55,000 | SEC↗ |
| RLYP Relypsa Inc | D To issuer | 2016-09-01 | 2016-09-02 | 55,000 | $32.00 | $1.76M | 0 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2016-09-01 | 2016-09-02 | 11,250 | — | $0 | 65,142 | SEC↗ |
| RLYP Relypsa Inc | F Tax w/h | 2016-08-15 | 2016-08-17 | 3,994 | $31.89 | $127.4K | 53,892 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2016-06-03 | 2016-06-07 | 22,500 | — | $0 | 22,500 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2016-06-03 | 2016-06-07 | 5,625 | — | $0 | 60,000 | SEC↗ |
| RLYP Relypsa Inc | F Tax w/h | 2016-06-03 | 2016-06-07 | 2,114 | $19.96 | $42.2K | 57,886 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2016-05-20 | 2016-05-24 | 9,260 | — | $0 | 9,260 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2016-05-20 | 2016-05-24 | 3,700 | — | $0 | 14,400 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | P Buy | 2016-02-12 | 2016-02-17 | 2,000 | $28.33 | $56.7K | 10,700 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2015-12-07 | 2015-12-09 | 10,000 | — | $0 | 727,877 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-12-07 | 2015-12-09 | 800 | $29.67 | $23.7K | 54,375 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-12-07 | 2015-12-09 | 7,379 | $28.52 | $210.4K | 55,175 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-12-07 | 2015-12-09 | 6,821 | $27.85 | $190.0K | 62,554 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2015-12-07 | 2015-12-09 | 10,000 | $7.40 | $74.0K | 69,375 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2015-12-04 | 2015-12-04 | 20,000 | — | $0 | 737,877 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2015-12-04 | 2015-12-04 | 20,000 | $7.40 | $148.0K | 79,375 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-12-04 | 2015-12-04 | 20,000 | $25.00 | $500.0K | 59,375 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2015-12-02 | 2015-12-04 | 20,000 | — | $0 | 757,877 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-12-02 | 2015-12-04 | 20,000 | $25.00 | $500.0K | 59,375 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2015-12-02 | 2015-12-04 | 20,000 | $7.40 | $148.0K | 79,375 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2015-11-06 | 2015-11-10 | 16,875 | — | $0 | 59,375 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2015-10-29 | 2015-11-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2015-10-29 | 2015-11-02 | 5,000 | — | $0 | 5,000 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-08-17 | 2015-08-19 | 2,366 | $25.00 | $59.1K | 42,500 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-08-17 | 2015-08-19 | 2,634 | $24.69 | $65.0K | 44,866 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2015-08-10 | 2015-08-12 | 105,000 | — | $0 | 105,000 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2015-08-10 | 2015-08-12 | 22,500 | — | $0 | 47,500 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2015-07-31 | 2015-08-03 | 5,000 | — | $0 | 777,877 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2015-07-31 | 2015-08-03 | 5,000 | $7.40 | $37.0K | 35,000 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-07-31 | 2015-08-03 | 200 | $34.14 | $6.8K | 25,000 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-07-31 | 2015-08-03 | 9,800 | $33.51 | $328.4K | 25,200 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2015-07-30 | 2015-08-03 | 20,000 | — | $0 | 782,877 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-07-30 | 2015-08-03 | 19,800 | $33.57 | $664.7K | 30,200 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2015-07-30 | 2015-08-03 | 20,000 | $7.40 | $148.0K | 50,000 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-07-30 | 2015-08-03 | 200 | $34.11 | $6.8K | 30,000 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2015-06-01 | 2015-06-02 | 8,555 | — | $0 | 802,877 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2015-06-01 | 2015-06-02 | 8,555 | $7.40 | $63.3K | 43,555 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-06-01 | 2015-06-02 | 8,351 | $35.79 | $298.9K | 35,204 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-06-01 | 2015-06-02 | 5,204 | $36.94 | $192.2K | 30,000 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2015-05-29 | 2015-06-02 | 20,000 | — | $0 | 811,432 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-05-29 | 2015-06-02 | 5,306 | $36.98 | $196.2K | 35,000 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2015-05-29 | 2015-06-02 | 20,000 | $7.40 | $148.0K | 55,000 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-05-29 | 2015-06-02 | 14,694 | $36.40 | $534.9K | 40,306 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2015-05-15 | 2015-05-19 | 9,260 | — | $0 | 9,260 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2015-05-15 | 2015-05-19 | 3,700 | — | $0 | 8,700 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2014-10-30 | 2014-10-31 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2014-08-14 | 2014-08-18 | 94,500 | — | $0 | 94,500 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2014-08-14 | 2014-08-18 | 20,000 | — | $0 | 35,000 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2014-01-10 | 2014-01-14 | 12,500 | $42.97 | $537.1K | 12,500 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2014-01-10 | 2014-01-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| RLYP Relypsa Inc | P Buy | 2013-11-20 | 2013-11-20 | 15,000 | $11.00 | $165.0K | 15,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2013-10-23 | 2013-10-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AFFY AFFYMAX INC | G Gift | 2013-06-28 | 2013-06-28 | 15,000 | — | $0 | 76,666 | SEC↗ |
| AFFY AFFYMAX INC | F Tax w/h | 2013-06-27 | 2013-06-28 | 16,334 | $1.02 | $16.7K | 91,666 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2013-02-01 | 2013-02-05 | 2,200 | — | $0 | 36,700 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2013-02-01 | 2013-02-05 | 4,166 | — | $0 | 158,347 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2013-02-01 | 2013-02-05 | 2,200 | $5.83 | $12.8K | 110,200 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2013-02-01 | 2013-02-05 | 4,166 | $6.90 | $28.7K | 114,366 | SEC↗ |
| AFFY AFFYMAX INC | S Sale | 2013-02-01 | 2013-02-05 | 6,366 | $18.81 | $119.7K | 108,000 | SEC↗ |
| AFFY AFFYMAX INC | A Award deriv | 2013-01-30 | 2013-02-01 | 96,000 | — | $0 | 96,000 | SEC↗ |
| AFFY AFFYMAX INC | A Award deriv | 2013-01-30 | 2013-02-01 | 32,000 | — | $0 | 32,000 | SEC↗ |
| AFFY AFFYMAX INC | A Award | 2013-01-30 | 2013-02-01 | 16,000 | — | $0 | 108,000 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2012-12-03 | 2012-12-04 | 12,498 | — | $0 | 162,513 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2012-12-03 | 2012-12-04 | 3,300 | — | $0 | 38,900 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2012-12-03 | 2012-12-04 | 12,498 | $6.90 | $86.2K | 107,798 | SEC↗ |
| AFFY AFFYMAX INC | S Sale | 2012-12-03 | 2012-12-04 | 15,798 | $24.22 | $382.6K | 92,000 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2012-12-03 | 2012-12-04 | 3,300 | $5.83 | $19.2K | 95,300 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2012-10-05 | 2012-10-09 | 41,664 | — | $0 | 175,011 | SEC↗ |
| AFFY AFFYMAX INC | S Sale | 2012-10-05 | 2012-10-09 | 41,664 | $22.50 | $937.4K | 92,000 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2012-10-05 | 2012-10-09 | 41,664 | $6.90 | $287.5K | 133,664 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2012-10-01 | 2012-10-03 | 3,300 | — | $0 | 42,200 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2012-10-01 | 2012-10-03 | 8,332 | — | $0 | 216,675 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2012-10-01 | 2012-10-03 | 3,300 | $5.83 | $19.2K | 95,300 | SEC↗ |
| AFFY AFFYMAX INC | S Sale | 2012-10-01 | 2012-10-03 | 11,632 | $21.04 | $244.7K | 92,000 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2012-10-01 | 2012-10-03 | 8,332 | $6.90 | $57.5K | 103,632 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2012-09-13 | 2012-09-17 | 37,497 | — | $0 | 225,007 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2012-09-13 | 2012-09-17 | 11,500 | — | $0 | 45,500 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2012-09-13 | 2012-09-17 | 11,500 | $5.83 | $67.0K | 140,997 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2012-09-13 | 2012-09-17 | 37,497 | $6.90 | $258.7K | 129,497 | SEC↗ |
| AFFY AFFYMAX INC | S Sale | 2012-09-13 | 2012-09-17 | 48,997 | $20.00 | $979.9K | 92,000 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2012-08-20 | 2012-08-22 | 37,496 | — | $0 | 262,504 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2012-08-20 | 2012-08-22 | 11,500 | — | $0 | 57,000 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2012-08-20 | 2012-08-22 | 37,496 | $6.90 | $258.7K | 140,996 | SEC↗ |
| AFFY AFFYMAX INC | S Sale | 2012-08-20 | 2012-08-22 | 48,996 | $17.50 | $857.4K | 92,000 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2012-08-20 | 2012-08-22 | 11,500 | $5.83 | $67.0K | 103,500 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2012-08-01 | 2012-08-03 | 1,100 | — | $0 | 68,500 | SEC↗ |
| AFFY AFFYMAX INC | S Sale | 2012-08-01 | 2012-08-03 | 1,100 | $16.31 | $17.9K | 92,000 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2012-08-01 | 2012-08-03 | 1,100 | $5.83 | $6.4K | 93,100 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2012-07-13 | 2012-07-17 | 2,200 | — | $0 | 69,600 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2012-07-13 | 2012-07-17 | 2,200 | $5.83 | $12.8K | 110,700 | SEC↗ |
| AFFY AFFYMAX INC | S Sale | 2012-07-13 | 2012-07-17 | 18,700 | $15.00 | $280.5K | 92,000 | SEC↗ |
| NGSX NeurogesX Inc | A Award deriv | 2012-06-07 | 2012-06-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AFFY AFFYMAX INC | S Sale | 2012-04-27 | 2012-05-01 | 30,000 | $13.35 | $400.5K | 108,500 | SEC↗ |
| AFFY AFFYMAX INC | S Sale | 2012-04-03 | 2012-04-05 | 16,500 | $11.93 | $196.8K | 138,500 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2012-03-27 | 2012-03-29 | 8,200 | — | $0 | 71,800 | SEC↗ |
| AFFY AFFYMAX INC | S Sale | 2012-03-27 | 2012-03-29 | 8,200 | $15.70 | $128.7K | 155,000 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2012-03-27 | 2012-03-29 | 8,200 | $5.83 | $47.8K | 163,200 | SEC↗ |
| NGSX NeurogesX Inc | A Award deriv | 2012-02-07 | 2012-02-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AFFY AFFYMAX INC | S Sale | 2012-02-02 | 2012-02-06 | 18,000 | $10.00 | $180.0K | 155,000 | SEC↗ |
| AFFY AFFYMAX INC | A Award deriv | 2012-01-31 | 2012-02-02 | 140,000 | — | $0 | 140,000 | SEC↗ |
| AFFY AFFYMAX INC | A Award | 2012-01-31 | 2012-02-02 | 25,000 | — | $0 | 173,000 | SEC↗ |